From isolated GH deficiency to multiple pituitary hormone deficiency: An evolving continuum - A KIMS analysis

European Journal of Endocrinology

Volumn 161, Issue SUPPL. 1, 2009, Pages

  Klose, M ^a   Jonsson, B ^b   Abs, R ^c   Popovic, V ^d   Koltowska Haggstrom M ^e   Saller, B ^f   Feldt Rasmussen, U ^a   Kourides, I ^e  

^a Rigshospitalet   (Denmark)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Belgrade University   (Serbia)

^e PFIZER INC   (United States)

^f PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; HYPOPHYSIS HORMONE;

AGE DISTRIBUTION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DATA COLLECTION METHOD; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOTHERAPY; SURGICAL TECHNIQUE; TREATMENT DURATION; ADULT; CRANIOPHARYNGIOMA; FACTUAL DATABASE; FEMALE; HYPOPHYSIS TUMOR; MALE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; TIME;

ADULT; AGE OF ONSET; CRANIOPHARYNGIOMA; DATABASES, FACTUAL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 70449849165     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0328     Document Type: Article

References (37)

1. Stochholm K, Gravholt CH, Laursen T, Laurberg P, Andersen M, Kristensen LO, Feldt-Rasmussen U, Christiansen JS, Frydenberg M & Green A. Mortality and GH deficiency: a nationwide study. European Journal of Endocrinology 2007 157 9-18.
2. Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Goth MI, Koltowska-Haggstrom M, Monson JP, Verhelst J & Wilton P. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone and IGF Research 2005 15 349-359. (Pubitemid 41408413)
3. Maiter D, Abs R, Johannsson G, Scanlon M, Jonsson PJ, Wilton P & Koltowska-Haggstrom M. Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database. European Journal of Endocrinology 2006 155 253-260. (Pubitemid 44269441)
4. Gutierrez LP, Koltowska-Haggstrom M, Jonsson PJ, Mattsson AF, Svensson D, Westberg B & Luger A. Registries as a tool in evidencebased medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiology and Drug Safety 2008 17 90-102. (Pubitemid 351187389)
5. Aetiology of growth hormone deficiency (KIMS classification list). In Growth Hormone Deficiency in Adults: 10 Years in KIMS, edn1, appendix D, pp 346-348. Eds R Abs & U Feldt-Rasmussen. Oxford: Oxford Pharma Genesis, 2004.
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497.
7. Friedewald W, Levy R & Frederickson D. Estimation of the concentration of low-densisty lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
8. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L & Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research 1999 8 373-383. (Pubitemid 29369642)
9. Riis P. Thirty years of bioethics: the Helsinki Declaration 1964-2003. New Review of Bioethics 2003 1 15-25.
10. Satterhwaite F. An approximate distribution of estimates of variance components. Biometrics Bulletin 1946 2 110-114.
11. Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P & Wuster C. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clinical Endocrinology 1999 50 703-713. (Pubitemid 29284503)
12. Klose M, Juul A, Poulsgaard L, Kosteljanetz M, Brennum J & Feldt- Rasmussen U. Prevalence and predictive factors of post-traumatic hypopituitarism. Clinical Endocrinology 2007 67 193-201. (Pubitemid 47076291)
13. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK & Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. Journal of the American Medical Association 2007 298 1429-1438. (Pubitemid 47481609)
14. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700.
15. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
16. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ & Hartman ML. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2002 87 2067-2079. (Pubitemid 34521490)
17. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA & Strasburger CJ. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. Journal of Clinical Endocrinology and Metabolism 1997 82 82-88. (Pubitemid 27021275)
18. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G & Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. European Journal of Endocrinology 1997 137 240-245. (Pubitemid 27405107)
19. Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt- Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B & Wilton P. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. Journal of Bone and Mineral Research 2001 16 398-405. (Pubitemid 32106717)
20. Holmes SJ, Economou G, Whitehouse RW, Adams JE & Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1994 78 669-674. (Pubitemid 24083309)
21. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E & Lombardi G. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 1999 84 1919-1924. (Pubitemid 30647010)
22. Toogood AA, Adams JE, O'Neill PA & Shalet SM. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. Journal of Clinical Endocrinology and Metabolism 1997 82 1462-1466. (Pubitemid 27200419)
23. Brabant G, Krogh RA, Biller BM, Buchfelder M, Feldt-Rasmussen U, Forssmann K, Jonsson B, Koltowska-Haggstrom M, Maiter D, Saller B & Toogood A. Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency. Journal of Clinical Endocrinology and Metabolism 2007 92 2604-2609. (Pubitemid 47037364)
24. Abdu TA, Neary R, Elhadd TA, Akber M & Clayton RN. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clinical Endocrinology 2001 55 209-216. (Pubitemid 32868585)
25. Beshyah SA, Henderson A, Niththyanathan R, Sharp P, Richmond W & Johnston DG. Metabolic abnormalities in growth hormone deficient adults: carbohydrate tolerance and lipid metabolism. Endocrinology and Metabolism 1995 1 173-180.
26. Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Goth MI, Wilton P & Koltowska-Haggstrom M. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis. European Journal of Endocrinology 2006 155 79-90. (Pubitemid 44109069)
27. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann- Hansen T, Skakkebaek NE & Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989 1 1221-1225. (Pubitemid 19140325)
28. Salomon F, Cuneo RC, Hesp R & Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989 321 1797-1803. (Pubitemid 20015573)
29. Cuneo RC, Salomon F, Watts GF, Hesp R & Sonksen PH. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 1993 42 1519-1523. (Pubitemid 24001166)
30. McGauley GA. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatrica Scandinavica 1989 356 70-72. (Pubitemid 19242170)
31. Koltowska-Haggstrom M, Hennessy S, Mattsson AF, Monson JP & Kind P. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency. Hormone Research 2005 64 46-54. (Pubitemid 41213298)
32. Carroll PV, Littlewood R, Weissberger AJ, Bogalho P, McGauley G, Sonksen PH & Russell-Jones DL. The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults. European Journal of Endocrinology 1997 137 146-153. (Pubitemid 27342229)
33. Koltowska-Haggstrom M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HP & Johannsson G. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? European Journal of Endocrinology 2006 155 109-119.
34. Hernberg-Stahl E, Luger A, Abs R, Bengtsson BA, Feldt- Rasmussen U, Wilton P, Westberg B & Monson JP. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 2001 86 5277-5281. (Pubitemid 33072095)
35. Svensson J, Mattsson A, Rosen T, Wiren L, Johannsson G, Bengtsson BA & Koltowska HM. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Hormone & IGF Research 2004 14 207-215. (Pubitemid 38691043)
36. Jorgensen JO, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE & Christiansen JS. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1989 69 1127-1132. (Pubitemid 20010037)
37. Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF & Monson JP. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clinical Endocrinology 2003 59 613-620. (Pubitemid 37357623)